Department of Cellular and Molecular Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, California 92093-0712, USA.
J Virol. 2010 Mar;84(6):3079-93. doi: 10.1128/JVI.02236-09. Epub 2009 Dec 30.
We have continued studies to further understand the role of the ubiquitin-proteasome system (UPS) in human cytomegalovirus (HCMV) infection. With specific inhibitors of the proteasome, we show that ongoing proteasome activity is necessary for facilitating the various stages of the infection. Immediate-early protein 2 expression is modestly reduced with addition of proteasome inhibitors at the onset of infection; however, both early and late gene expression are significantly delayed, even if the inhibitor is removed at 12 h postinfection. Adding the inhibitor at later times during the infection blocks the further accumulation of viral early and late gene products, the severity of which is dependent on when the proteasome is inhibited. This can be attributed primarily to a block in viral RNA transcription, although DNA synthesis is also partially inhibited. Proteasome activity and expression increase as the infection progresses, and this coincides with the relocalization of active proteasomes to the periphery of the viral DNA replication center, where there is active RNA transcription. Interestingly, one 19S subunit, Rpn2, is specifically recruited into the viral DNA replication center. The relocalization of the subunits requires viral DNA replication, but their maintenance around or within the replication center is not dependent on continued viral DNA synthesis or the proteolytic activity of the proteasome. These studies highlight the importance of the UPS at all stages of the HCMV infection and support further studies into this pathway as a potential antiviral target.
我们继续研究以进一步了解泛素-蛋白酶体系统 (UPS) 在人巨细胞病毒 (HCMV) 感染中的作用。使用蛋白酶体的特定抑制剂,我们表明持续的蛋白酶体活性对于促进感染的各个阶段是必要的。在感染开始时添加蛋白酶体抑制剂,可适度降低即刻早期蛋白 2 的表达;然而,早期和晚期基因的表达均显著延迟,即使在感染后 12 小时去除抑制剂也是如此。在感染过程中较晚时间添加抑制剂会阻止病毒早期和晚期基因产物的进一步积累,其严重程度取决于何时抑制蛋白酶体。这主要归因于病毒 RNA 转录的阻断,尽管 DNA 合成也部分受到抑制。随着感染的进展,蛋白酶体活性和表达增加,这与活性蛋白酶体向病毒 DNA 复制中心周围的重新定位相吻合,在那里有活跃的 RNA 转录。有趣的是,一个 19S 亚基 Rpn2 被特异性募集到病毒 DNA 复制中心。亚基的重新定位需要病毒 DNA 复制,但它们在复制中心周围或内部的维持并不依赖于持续的病毒 DNA 合成或蛋白酶体的蛋白水解活性。这些研究强调了 UPS 在 HCMV 感染的所有阶段的重要性,并支持进一步研究该途径作为一种潜在的抗病毒靶点。